NCT04310189View on ClinicalTrials.gov

The Role of IL-22/IL-22BP Axis in Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

November 29, 2022

Study Completion Date

November 29, 2022

Conditions
Atopic Dermatitis
Interventions
PROCEDURE

Biopsy

All patients will have a blood sample and 2 skin biopsies (2 mm diameter) in lesional and non lesional area

Trial Locations (1)

Unknown

Nantes University Hospital, Nantes

All Listed Sponsors
collaborator

Plateforme CIMNA, Laboratoire d'Immunologie, Nantes University Hospital

UNKNOWN

collaborator

UCB Biopharma SRL

INDUSTRY

lead

Nantes University Hospital

OTHER

NCT04310189 - The Role of IL-22/IL-22BP Axis in Atopic Dermatitis | Biotech Hunter | Biotech Hunter